References
- Global initiative for asthma. January, 1995, NHLBI/WHO Workshop Report. Publication no. 95–3659
- Wanner A. Is the routine use of inhaled β-adrenergic agonists appropriate in asthma treatment? YES. Am J Respir Crit Care Med 1995; 151: 597
- Sears M. Is the routine use of inhaled β-adrenergic agonists appropriate in asthma treatment? NO. Am J Respir Crit Care Med 1995; 151: 600
- Barrett T E, Strom B L. Inhaled beta-adrenergic receptor agonists in asthma: More harm than good?. Am J Respir Crit Care Med 1995; 351: 574
- Van Schayck C P, Cloosterman S GM, Hofland I D, van Herwaarden C LA, van Weel C. How detrimental is chronic use of bronchodilators in asthma and chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 1995; 752: 1317
- Taylor D R, Sears M R. Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed. Chest 1994; 206: 552
- Cheung D, Timmers M C, Zwinderman A H, Bel E H, Dijkman J H, Sterk P J. Long-term effects of a long-acting β2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992; 327: 1198
- Sears M R, Taylor D R, Print C G, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391
- Chapman K R, Kesten S, Szalai J P. Regular vs as-needed salbutamol in asthma control. Lancet 1994; 343: 1379
- Heino M. Regularly inhaled β-agonists with steroids are not harmful in stable asthma. J. Allergy Clin Immunol 1994; 93: 80
- Greening A P, Ind P W, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219
- Wahedna I, Wong C S, Wisniewski A FZ, Pavord I D, Tattersfield A E. Asthma control during and after cessation of regular beta2-agonist treatment. Am Rev Respir Dis 1993; 148: 707
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225
- European Respiratory Society. Standardized lung function testing. Eur Respir J 1993; 6((Suppl 16))
- Eichenhorn M S, Beauchamp R K, Harper P A, Ward J C. An assessment of three portable peak flow meters. Chest 1982; 82: 302
- Sears M R, Taylor D R, Print C G, et al. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma. Chest 1992; 102: 1709
- Page C, Costello J. Why β-agonists should not be used regularly. Respir Med 1992; 86: 477
- Kraan J, Koeter G H, Mark Th W, Sluiter H J, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628
- Van Schayck C P, Graafsma S J, Visch M B, Dompeling E, van Weel C, van Herwaarden C LA. Increased bronchial responsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 1990; 86: 793